Mangoceuticals inc MGRX.US 總覽分析
MGRX 投資分析
看多重點：
- 價值≥4
- 股利≥2
分析結論
公司發布財報數據季度不足，尚無法提供評分
MGRX 近期報酬表現
4.35%
Mangoceuticals inc
3.56%
同產業平均
1.47%
S&P500
與 MGRX 同產業的標的表現
- DRUG Bright minds biosciences inc價值 2 分趨勢 2 分波段 2 分籌碼 -股利 1 分查看更多
MGRX 公司資訊
Mangoceuticals, Inc. is focused on developing men's and women's health and wellness products and services via a secure telemedicine platform. The Company connects consumers to licensed healthcare professionals through its Website at www.MangoRX.com, for the provision of care via telehealth on its customer portal. It has developed and is commercially marketing a brand of erectile dysfunction (ED) products under the brand name Mango, a brand of hair-loss products under the brand name Grow, a brand of hormone balance and therapy products under the name Mojo, and a brand of weight-loss products under the brand name Slim. The Mango ED product includes the three ingredients: Either Sildenafil (the active ingredient in Viagra) or Tadalafil (the active ingredient in Cialis), and Oxytocin. Mango GROW includes four ingredients: Minoxidil (the active ingredient in Rogaine) and Finasteride (the active ingredient in Propecia), Vitamin D3 and Biotin, which are available as dietary supplements.